Alzheimer Diagnosis Current Events | Alzheimer Diagnosis News
|
| Page
1 of
26 |
505 Results |
|
|
|
Sort By:
Page Views | Date |
NEW MAPPING TECHNIQUE FOR EARLIER DETECTION OF ALZHEIMER’S DISEASE (p 201)
An Early Report in this week’s issue of THE LANCET outlines an imaging technique that could identify the early progression of Alzheimer’s disease before the onset of clinical symptoms. The early diagnosis and monitoring of the progression of Alzheimer’s disease is important for the development of therapeutic strategies aimed at... view more... (2001-07-18)
New biomarkers could help doctors spot Alzheimer's and other neurodegenerative diseases
Neurodegenerative diseases like Alzheimer's and Parkinson's in their early stages can be difficult for physicians to spot, and many diagnoses are incorrect. view more (2006-08-14)
Drugs may not delay onset of dementia; and more
Researchers have examined the evidence in favour of giving people considered to be close to developing dementia the drugs that are most commonly used to treat the condition itself. view more (2007-11-27)
Counselling people with dementia:
People with dementia can learn to cope with their fears and worries and to express their feelings – “Even if I forget my facts, I can remember my feelings!” said one 68 year old lady with Alzheimer’s Disease. view more (2002-07-02)
Alzheimer's disease progresses more rapidly in highly educated people
High levels of education may help ward off Alzheimer's disease, but they also speed up its progression once developed, reveals research in the Journal of Neurology Neurosurgery and Psychiatry. view more (2006-02-16)
Imaging study links key genetic risk for Alzheimer's disease to myelin breakdown
A new UCLA imaging study shows that age-related breakdown of myelin, the fatty insulation coating the brain's internal wiring, correlates strongly with the presence of a key genetic risk factor for Alzheimer disease. view more (2006-01-03)
Study implicates defective synapse generator in onset of Alzheimer's
A new UCLA/Veterans Affairs study implicates defects in the machinery that creates connections between brain cells as responsible for the onset of Alzheimer disease. view more (2006-01-27)
CPAP improves sleep in patients with Alzheimer's disease, sleep-related breathing disorder
Patients with both Alzheimer disease and a sleep-related breathing disorder (SRBD) experience disrupted sleep, resulting in increased nocturnal awakenings and a decreased percentage of REM sleep. view more (2007-06-11)
Blood clots may hold key to treating dementia
Spontaneous blood clots or debris from arterial disease in the brain (known as cerebral emboli) may hold the key to preventing or treating dementia, say researchers from the University of Manchester in this week's BMJ. view more (2006-04-28)
Ground-breaking new insight into the development of Alzheimer's disease
According to estimates there are 85,000 Alzheimer patients in our country and approximately 20,000 new cases every year. This spectacular increase is due to the increasing ageing population. Unfortunately it is still unclear precisely which ageing process forms the basis of this spectacular rise in the occurrence of the disease. view more (2008-04-23)
Alzheimer's pathology related to episodic memory in those without dementia
Alzheimer's pathology can appear in the brains of older men and women without dementia or mild cognitive impairment. view more (2006-06-27)
Alzheimer disease and the blood brain barrier: Is Abeta transport the key?
Increased production of the amyloid-beta (Abeta) peptide can lead to Abeta aggregation and buildup in the brain and rare familial forms of early onset Alzheimer disease (AD). view more (2005-10-21)
Link between Alzheimer's disease and traumatic brain damage clarified
This week scientists of the Flanders Interuniversity Institute for Biotechnology (VIB) will once again publish a breakthrough in their research regarding Alzheimer's disease. view more (2005-08-04)
Chemistry & Industry Issue 1 - Cover Date Monday 7 January 2002
From Issue 1 2002 Chemistry & Industry has a new look and updated contents, including the launch of the C&I stock price indices. Based on the price of shares in 22 blue chip chemicals companies in Europe and North America, the value of the portfolio has been normalized to 100 and we await developments. Its value will be printed fortnightly on... view more... (2002-01-02)
Another McGill/JGH breakthrough opens door to early Alzheimer's diagnosis
A new diagnostic technique which may greatly simplify the detection of Alzheimer's disease has been discovered by researchers at McGill University and the affiliated Lady Davis Institute for Medical Research at Montreal's Jewish General Hospital (JGH). view more (2009-06-17)
New synthetic compounds appear to prevent brain cell death
Spanish chemists have developed a promising set of synthetic compounds that one day could help slow or perhaps halt the progression of Alzheimer's disease and other neurological disorders. view more (2005-12-21)
Intake of dietary copper helps Alzheimer's patients
As one of the services for patients with Alzheimer's disease, the Department of Psychiatry at the Saarland University Medical Center offers participation in a clinical phase II trial. This clinical trial aims to elucidate a potential beneficial effect of copper orotate (an organic copper salt), which is given together with a standard... view more... (2005-10-04)
Researchers map links between size of hippocampus and progression to Alzheimer's dementia
UCLA researchers sought to test the theory that the hippocampus - the area of the brain that processes memory - is smaller in patients with mild cognitive impairment who develop into Alzheimer's dementia, and that it is larger in patients with mild cognitive impairment who experience cognitive stability or improvement. view more (2006-05-09)
Higher folate levels linked to reduced risk for Alzheimer's disease
Individuals who take in higher levels of the nutrient folate through both diet and supplements may have a reduced risk of developing Alzheimer's disease. view more (2007-01-09)
Memantine appears effective and safe in moderate to severe Alzheimer's disease
Memantine, a drug approved for the treatment of Alzheimer disease, appears safe and effective in patients with moderate to severe cases of the condition, according to a study in the January issue of Archives of Neurology. view more (2006-01-10)
|
|
| Page
1 of
26 |
505 Results |
|
|
|
Sort By:
Page Views | Date |
|
